Skip to main content
Displaying 1 - 12 of 18
Display:
12
24
48
Metabolism, Alcohol & Toxicity
Welcome and Introduction
Webcasts
View
Metabolism, Alcohol & Toxicity
Sanofi: Reducing the burden of liver disease - new evidence revealed (Complete Session)
Webcasts
View
Metabolism, Alcohol & Toxicity
MAFLD in Focus: Unveiling Insights from RELIEF Study - Insight from APASL 2024
Webcasts
View
Metabolism, Alcohol & Toxicity
Metabolic and toxic liver damage in focus - MANPOWER's Latest Breakthroughs Revealed.
Webcasts
View
Metabolism, Alcohol & Toxicity
Shedding light on genomic, metabolic, and phenotypic effects of essential phospholipids on HepaRG
Webcasts
View
Metabolism, Alcohol & Toxicity
Metabolic Comorbidities Unmasked - Redefining MASLD/MASH Impact
Webcasts
View
Metabolism, Alcohol & Toxicity
Q&A
Webcasts
View
Metabolism, Alcohol & Toxicity
Summary and closing remarks
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Understanding New Goals of Therapy in PBC
Webcasts
View
Immune-Mediated and Cholestatic Diseases
CymaBay Therapeutics: “Targeting New Approaches in PBC” (Complete Session)
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Q&A
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Welcome and Introduction
Webcasts
View
Pagination
Current page
1
Page
2
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy